1.The study process of diseases heterogeneity
International Journal of Traditional Chinese Medicine 2013;(6):516-519
Objective The purpose of this report is to improve the recovery rate of diseases by integrating the advantages of mature treatment programs,with the method of diseases heterogeneity research.Methods Two programs (each program consist of effective group and invalid group) were took into investigation to study the characteristics of heterogeneity.If it showed that heterogeneous differences exist between the two effective groups,then we would treat the patients in different ways.Results The total effective rate of heterogeneous treatment was better than that of current optimal treatments.Conclusion Heterogeneous treatment could be applied to all diseases,either to TCM or to western medicine diseases.If the heterogeneous treatment can be popularized,it would improve the recovery rate of diseases surely.
2.New ideas in research of the diseases' heterogeneity
International Journal of Traditional Chinese Medicine 2013;(5):416-418
Research of diseases' heterogeneity is a study method,which is based on the current ideas of single-program of clinical research,by means of searching the heterogeneous feature that corresponding to therapeutic schedule,optimizing and integrating the mature treatment programs,and aiming to improve diseases' recovery rate.Its characteristic is that it can integrate the advantages of current mature treatment programs,and make optimal effect.In this paper,we put forward the background,methods and ideas in the research of diseases' heterogeneity.
3.Specific applications of diseases' Heterogeneity-cake segmentation
International Journal of Traditional Chinese Medicine 2013;35(9):796-798
There are two treatments of A and B for disease X,if B replaced A,some patients that effective originally may become invalid.That is,the new drugs can increase the efficiency but may keep the effective patients out of the crowd at the same time.In this paper,we put forward the method of cake segmentation based on the principle of diseases' heterogeneity,optimize and make up the effective programs at present.The treatment based on diseases' heterogeneity will replace the best medicines currently,and format new treatments.
4.Diseases heterogeneity research applied to syndrome differentiation of prescription
International Journal of Traditional Chinese Medicine 2013;35(8):704-706
Syndrome differentiation of prescription is a more practical,simple and effective method which is distinguished from syndrome differentiation with eight principals,syndrome differentiation of viscera and syndrome differentiation of Wei Qi Ying Xue.However,after the ages of classical prescriptions,most of the current prescriptions,even ones from many experienced herb doctors' experiences,were seldom to summarize the syndrome corresponding to the prescription so precisely and to obtain reliable effect like the classical prescriptions.In this paper,by the research of diseases heterogeneity,we hope to excavate the syndrome which can correspond to the prescriptions of Chinese herbs and to set up a lot of prescriptions that can combine prescription and syndrome perfectly just like the classical ones in order to guide clinical treatment more conveniently and effectively.
5.Expression of CXCR4/CXCL12 and effect on the expression of CXCR4 by hypoxia in trophoblasts of human first trimester gestation
Yiying WANG ; Li ZOU ; Yun YANG
Chinese Journal of Immunology 2000;0(11):-
Objective:To investigate the expression of CXCR4/CXCL12 and effect on the expression of CXCR4 by hypoxia in trophoblasts of human first trimester gestation.Methods:To detect the expression of CXCR4 and CXCL12 in placental tissue and primary cytotrophoblasts by immunohistochemistry and to assess the level of CXCR4mRNA under the condition of hypoxia in the trophoblasts of first trimester gestation by reas-time PCR.Results:The expression of CXCR4/CXCL12 were detected in the villous column,blood vessels and trophoblasts in the early pregnancy;CXCR4 mRNA was significantly higher through 12,24,48 and 72 h incubation periods in the hypoxic condition than that under normal oxygen condition respectively.Conclusion:Human first trimester trophoblasts produced CXCR4/CXCL12,which may play important biological role on the normal human pregnancy;Hypoxia could regulate the expression of CXCR4,which may contribute to the physiological pregnancy process.
6.Study of effect of clenbuterol,a β2-adrenoceptor agonist on the recovery of locomotor function following spinal cord injury in rats
Yan ZHANG ; Yiying LI ; Jizong ZHAO ; Shuo WANG ; Xiangming LIU
Chinese Journal of Rehabilitation Theory and Practice 2005;11(7):546-547
ObjectiveTo determine whether the β2-agonist, clenbuterol, can improve recovery of locomotor function following spinal cord injury.MethodsThe spinal cords of rats were contused with a weight-drop apparatus similar to the NYU impactor at the lever of T10. Locomotor function was determined with the Basso, Beattie, Bresnahan (BBB) Scale. Following 6 weeks of behavioral evaluation, the spinal cords were received histological examination.ResultsClenbuterol improved the recovery of locomotor function and increased the amount of spared spinal cord tissue.ConclusionClenbuterol caused the enhancement of recovery of locomotor function and spared spinal cord tissue following contusion.
7.Nursing about patients with cerebral arteriovenous malformation received Onyx endovascular embolization
Yiying LI ; Hong MA ; Lili WANG ; Peijuan REN
Chinese Journal of Rehabilitation Theory and Practice 2005;11(9):774-775
ObjectiveTo explored the nursing about the patients received Onyx embolization. Methods14 patient with cerebral arteriovenous malformation received Onyx embolization were analyzed retrospectively.ResultsThere was no long-term complication occurred, and all the patients left hospital 3~6 d after operation. ConclusionIntensive nursing on lowered blood-pressure control was the most important process to keep embolization effect successfully.
8.To Write The Medical Research Contract From The Angle of Funding Management
Peijuan REN ; Yilong WANG ; Lu CHEN ; Yiying LI
Chinese Journal of Medical Science Research Management 2015;28(3):222-224,230
Medical research contract is an important part of business between medical research organizations.It is the official document identifying the right and obligations of respective medical research organizations during research activities.It is the legal basis,and is also on the basis of research expenditure.Therefore,it is very important to improve ability of the contract writing in research management.Composing a sound medical research contract has significant importance in research activities.This paper explored the remarkable issues when composing a medical research contract from the respective of management of funding,including how to make the contract more fair,rational,rigorous and legal.
9.Analysis on influence factors of autologous peripheral blood stem cell mobilizationand collection in 48 patients with non-Hodgkin′s lymphoma
Yiying XIONG ; Lin LIU ; Xiaoqiong TANG ; Qing XIAO ; Hongbin ZHANG ; Jianyu WANG ; Li WANG
Chongqing Medicine 2017;46(24):3328-3331
Objective To retrospectively analyze the influence factors during autologous peripheral blood stem cell (PBSC) mobilization and collection process in the patients with non-Hodgkin′s lymphoma (NHL).Methods Forty-eight patients with NHL in our hospital from January 2014 to August 2016 underwent PBPC mobilization and collection.The factors of age,sex,disease stage,bone marrow involvement at diagnosis,chemotherapy frequency,relapse and so on were analyzed retrospectively.Results PBSC mobilization and collection was successful in 37 cases (77.10%).The success rate was affected by the time from diagnosis to mobilization (P=0.038),chemotherapy courses (P=0.016),prior chemotherapy including fludarabine (P=0.049),relapse(P=0.033),and the levels of white blood cell (P=0.014) and platelet (P<0.01) before stem cells collection.Conclusion For the patients planning to receive autologous peripheral blood stem cell transplantation,many times of prior chemotherapy are unfavorable,mobilization and collection should be taken as early as possible,chemotherapeutic agents which possibly injure stem cells should be avoided,it is needed to simultaneously pay attention to peripheral blood WBC and platelet level for determining the collection timing.
10.Clinical Efficacy of Integrative Medicine in Treatment of Nine HIV/AIDS-associated Non-infectious Skin Lesion Cases
Shuchun YANG ; Jianqing YE ; Yiying WANG ; Xiulan MA ; Jingru LI ; Jianping MA
World Science and Technology-Modernization of Traditional Chinese Medicine 2015;(10):2094-2098
This study was aimed to observe the clinical efficacy of Highly Active Antiretroviral Therapy (HAART) combined withPing-Ai(PA) Mixture in the treatment of Human Immunodeficiency Virus / Acquired Immunodeficiency Syndrome (HIV/AIDS) patients with non-infectious skin lesions, in order to study the advantages of integrative medicine in AIDS prevention and treatment. A total of 9 cases, who met the inclusion criteria of AIDS-associated non-infectious skin lesion with the pattern ofqi-yin deficiency and internal obstruction of phlegm-stasis, were selected. The combination of HAART and number 1 and 4 prescription of PA Mixture were used in the treatment for 3 months. The observations were made on changes of clinical symptoms, body signs, Karovsky integral and CD4+ T cells of patients before and after treatment. Stata 12.0 was used in the statistical analysis. The results showed that after integrative therapy, the single integral of clinical symptoms and body signs, such as skin spot papula, subcutaneous nodules, skin itching, fatigue was obviously reduced compared to that of the pretreatment. The total score decreased than that of the pretreatment. The patients’ quality of life (QOL) significantly increased. The Karovsky integral increased compared with that of pretreatment. The CD4+ T cells values were higher than that of the pretreatment. It was concluded that the integrative therapy had a certain effect in the treatment of AIDS-associated non-infectious skin lesions, which can improve the clinical symptoms, body signs, obviously increase the patients’ QOL and immune function.